Literature DB >> 15063561

Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues.

Udi Qimron1, Lada Paul, Erez Bar-Haim, Noga Bloushtain, Lea Eisenbach, Herman F Staats, Angel Porgador.   

Abstract

Directed dissemination of Ag-specific CD8(+) T cells to infected organs or cancerous tissues is a prerequisite for optimal immunotherapy. Ag-specific CD8(+) T cells were quantitated in systemic and mucosal tissues after nasal, rectal, or cutaneous immunization with CTL epitope peptide and the adjuvant cholera toxin (CT). Mucosal and cutaneous immunization induced Ag-specific CD8(+) lymphocytes that were detectable in both mucosal and systemic compartments, suggesting a less strict distribution pattern than that known for B cells. However, optimal localization, activation and phenotype of these cells correlated with the route of immunization. In accordance with this observation, protection against a mucosal challenge with a virus expressing the CTL epitope was superior in mucosally-immunized animals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063561     DOI: 10.1016/j.vaccine.2003.11.043

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Systemic and mucosal infection program protective memory CD8 T cells in the vaginal mucosa.

Authors:  Pratima Krishna Suvas; Heather M Dech; Fleurette Sambira; Junwei Zeng; Thandi M Onami
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

Review 2.  GUCY2C-targeted cancer immunotherapy: past, present and future.

Authors:  Adam E Snook; Michael S Magee; Scott A Waldman
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.

Authors:  Shailbala Singh; Guojun Yang; Siddappa N Byrareddy; Michael A Barry; K Jagannadha Sastry
Journal:  Vaccine       Date:  2014-11-02       Impact factor: 3.641

4.  Acute exacerbations in COPD and their control with oral immunization with non-typeable haemophilus influenzae.

Authors:  Robert L Clancy; Margaret Dunkley
Journal:  Front Immunol       Date:  2011-03-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.